[Blind liver biopsy in general clinical diagnosis].
D000367:Age Factors; D000437:Alcoholism / Q000150:complications; D000686:Amyloidosis / Q000473:pathology; D001706:Biopsy / Q000009:adverse effects; D001778:Blood Coagulation Disorders / Q000150:complications; D002908:Chronic Disease; D005234:Fatty Liver / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000503:physiopathology; D006402:Hematologic Diseases / Q000473:pathology; D006505:Hepatitis / Q000473:pathology; D006529:Hepatomegaly / Q000175:diagnosis; D006801:Humans; D006932:Hyperbilirubinemia / Q000503:physiopathology; D007244:Infectious Mononucleosis / Q000473:pathology; D008099:Liver / Q000201:enzymology / Q000473:pathology*; D008103:Liver Cirrhosis / Q000473:pathology; D008107:Liver Diseases / Q000473:pathology*; D008113:Liver Neoplasms / Q000473:pathology; D008297:Male; D012507:Sarcoidosis / Q000473:pathology; D000637:Transaminases / Q000378:metabolism
D000637:Transaminases
Die Leberblindpunktion in der klinischen Allgemeindiagnostik.